Assessment of urinary cystatin C levels in HIV-1-infected patients with preserved kidney function

1Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

Introduction: Chronic kidney disease in one of the significant chronic conditions in human immunodeficiency virus (HIV)-infected population. The nephrotoxicity of antiretroviral therapy, particularly tenofovir disoproxil fumarate, is the important cause of kidney function impairment. There is a need to find reliable markers of early kidney damage. The aim of the study was to evaluate utility of urinary cystatin C levels as a marker of early kidney tubular damage in HIV-1-infected patients. Material and methods: A total of 119 HIV-1-infected patients (88 males, 74.0%) both on antiretroviral therapy (98 individuals, 82.4%) and treatment-naive, without known kidney disease, and 31 healthy volunteers were enrolled. Cystatin C levels in urine were measured and urine cystatin C/creatinine ratio (UCCR) was calculated. Results: Significantly higher levels of urinary cystatin C were observed in HIV-1-infected group and subgroup on antiretroviral therapy with current CD4+ count below 500 cells/μl (p = 0.008 and p = 0.005, respectively). In patients with albuminuria, both urinary cystatin C and UCCR were significantly higher (p = 0.0035 and p < 0.001, respectively). HIV-1 infection, detectable HIV RNA, low CD4+ nadir, antiretroviral treatment or its length, use of tenofovir, or protease inhibitors had no influence on urinary cystatin C and UCCR. Conclusions: Low current CD4+ cell count was the only HIV-1-related factor influencing urinary cystatin C level. Use of tenofovir or other potentially nephrotoxic antiretroviral drugs did not have any impact on urinary cystatin C levels. Albuminuria was related to higher levels of urinary cystatin C but the background and relevance of this finding is unclear. Utility of urinary cystatin C assessment requires further research in large populations.

Cite

CITATION STYLE

APA

Szymczak, A., Szymanek-Pasternak, A., Zalewska, M., Małyszczak, K., Rymer, W., & Knysz, B. (2018). Assessment of urinary cystatin C levels in HIV-1-infected patients with preserved kidney function. HIV and AIDS Review, 17(4), 236–242. https://doi.org/10.5114/hivar.2018.80254

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free